1. Home
  2. CDNA vs MTX Comparison

CDNA vs MTX Comparison

Compare CDNA & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$66.83

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

N/A

Current Price

$65.33

Market Cap

2.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
MTX
Founded
1998
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2007
2004

Fundamental Metrics

Financial Performance
Metric
CDNA
MTX
Price
$66.83
$65.33
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$58.83
★ $92.50
AVG Volume (30 Days)
★ 1.0M
126.6K
Earning Date
11-03-2026
10-22-2026
Dividend Yield
N/A
★ 0.73%
EPS Growth
N/A
★ N/A
EPS
★ 2.13
N/A
Revenue
$48,324,000.00
★ $2,072,600,000.00
Revenue This Year
$30.36
$5.45
Revenue Next Year
$6.23
$4.81
P/E Ratio
$30.04
★ N/A
Revenue Growth
★ 18.93
N/A
52 Week Low
$13.95
$53.94
52 Week High
$65.50
$84.34

Technical Indicators

Market Signals
Indicator
CDNA
MTX
Relative Strength Index (RSI) 78.88 25.55
Support Level $17.26 $63.65
Resistance Level N/A $70.69
Average True Range (ATR) 2.87 1.40
MACD 0.90 -0.19
Stochastic Oscillator 99.39 0.00

Price Performance

Historical Comparison
CDNA
MTX

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

Share on Social Networks: